Vanda asks US judge to reach Appointments Clause issue now
MLex Summary: Vanda Pharmaceuticals renewed its motion for summary judgment that the generic drug approval process by the US Food and Drug Administration violates the Appointments Clause of the US Constitution.See...To view the full article, register now.
Already a subscriber? Click here to view full article